BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24394665)

  • 21. E6AP inhibits G-CSFR turnover and functions by promoting its ubiquitin-dependent proteasome degradation.
    Chhabra S; Kumar Y; Thacker G; Kapoor I; Lochab S; Sanyal S; Bhatt MLB; Chattopadhyay N; Trivedi AK
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1545-1553. PubMed ID: 28578910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
    Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
    Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
    Benkö I; Maródi L; Megyeri A; Káposzta R; Kovács P
    Acta Physiol Hung; 1996; 84(3):261-2. PubMed ID: 9219597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.
    Aprikyan AA; Liles WC; Rodger E; Jonas M; Chi EY; Dale DC
    Blood; 2001 Jan; 97(1):147-53. PubMed ID: 11133754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia.
    Kobayashi M; Yumiba C; Kawaguchi Y; Tanaka Y; Ueda K; Komazawa Y; Okada K
    Blood; 1990 Jun; 75(11):2143-9. PubMed ID: 1693298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
    Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
    Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia.
    Tsunogake S; Nagashima S; Maekawa R; Takano N; Kajitani H; Saito K; Enokihara H; Furusawa S; Shishido H
    Int J Hematol; 1991 Jun; 54(3):251-6. PubMed ID: 1720982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential binding activity of the transcription factor LIL-STAT in immature and differentiated normal and leukemic myeloid cells.
    Tuyt LM; Bregman K; Lummen C; Dokter WH; Vellenga E
    Blood; 1998 Aug; 92(4):1364-73. PubMed ID: 9694725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
    McLemore ML; Poursine-Laurent J; Link DC
    J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
    Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G
    J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
    Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
    Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
    Qiu Y; Zhuang D; MacRae A; Dong F
    Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia.
    Zhuang D; Qiu Y; Kogan SC; Dong F
    J Biol Chem; 2006 Apr; 281(16):10745-51. PubMed ID: 16500901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
    Skokowa J; Steinemann D; Katsman-Kuipers JE; Zeidler C; Klimenkova O; Klimiankou M; Unalan M; Kandabarau S; Makaryan V; Beekman R; Behrens K; Stocking C; Obenauer J; Schnittger S; Kohlmann A; Valkhof MG; Hoogenboezem R; Göhring G; Reinhardt D; Schlegelberger B; Stanulla M; Vandenberghe P; Donadieu J; Zwaan CM; Touw IP; van den Heuvel-Eibrink MM; Dale DC; Welte K
    Blood; 2014 Apr; 123(14):2229-37. PubMed ID: 24523240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
    Liu F; Kunter G; Krem MM; Eades WC; Cain JA; Tomasson MH; Hennighausen L; Link DC
    J Clin Invest; 2008 Mar; 118(3):946-55. PubMed ID: 18292815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal responsiveness of granulocyte-committed progenitor cells in cyclic neutropenia.
    Hammond WP; Chatta GS; Andrews RG; Dale DC
    Blood; 1992 May; 79(10):2536-9. PubMed ID: 1375103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter.
    Bellon T; Perrotti D; Calabretta B
    Blood; 1997 Sep; 90(5):1828-39. PubMed ID: 9292515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.